CTOs on the Move

Vero Biotech

www.vero-biotech.com

 
Inhaled nitric oxide has the potential to benefit patients, with a range of cardiopulmonary conditions including COVID-19 Coronavirus.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Vero Biotech raised $50M on 01/20/2021

Similar Companies

AmerisourceBergen Specialty Group

For pharmaceutical manufacturers and healthcare providers, AmerisourceBergen Specialty Group is an essential business partner.

Health Supply US

Health Supply US provides America’s leading health care facilities and first responder networks and governments with Personal Protective Equipment (PPE), Sanitizers, and COVID Testing Kits among other devices and supplies. We service government at all ...

Advanced Urology

Advanced Urology provides cutting-edge Vasectomy, Circumcision, InterStim, Urolift, Cytoscopy, TURP, Vasectomy Reversal & IPP. Contact us today for an initial consult.

Low T Center

Low T Center, mens health clinic, offers treatment for low t levels with testosterone replacement therapy, (hormone replacement), and sleep apnea .

Radionetics

Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications. The company`s platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes to a broad range of cancers by binding selectively to peptide receptors that are selectively expressed on these tumors. This nonpeptide technology addresses many of the significant challenges currently facing peptide and protein targeted radiotherapeutics, particularly in the realm of optimizing drug-like characteristics and manufacturing. The company is rapidly advancing a pipeline of drug candidates to treat a broad range of cancers and is conducting additional drug discovery efforts to identify drug candidates for additional receptor targets in collaboration with Crinetics Pharmaceuticals.